Jingfeng Pharmaceutical(SZ:000908) Sou Hu Cai Jing·2025-07-25 08:30Group 1 - The core viewpoint of the articles highlights the financial performance and market position of ST Jingfeng, indicating a current stock price of 5.88 yuan with a PE ratio of 36.55 times, which is lower than the industry average of 61.55 times [1][3] - The company has a total market capitalization of 5.173 billion yuan, ranking 94th in the chemical pharmaceutical industry based on PE ratio [1][3] - Recent funding trends show a net inflow of 6.0358 million yuan on July 25, but a total outflow of 12.6988 million yuan over the past five days [1] Group 2 - Hunan Jingfeng Pharmaceutical Co., Ltd. specializes in the research, manufacturing, and sales of pharmaceutical products, with key products including various injections and capsules, many of which are unique or under national medical insurance [2] - The company is actively expanding its product line and has several products that have received clinical approval or are in clinical research stages [2]